Oregon · A9537

Technetium Tc-99m Mebrofenin, Diagnostic, Per Study Dose, Up To 15 Millicuries in Oregon

Oregon Medicare Avg
$46.85
36% above national avg
National Medicare Avg
$34.35
All states combined
Billed Charge (OR)
$72.32
What providers submit
Est. Commercial (OR)
$134.86
National avg: $97.11
Est. Cash / Self-Pay (OR)
$63.87
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

37
Services in OR
15
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Oregon

Provider Medicare Services
Greenberg, David MD $47.57 15

Oregon Pricing in Context

In Oregon, CPT code A9537 (Technetium Tc-99m Mebrofenin, Diagnostic, Per Study Dose, Up To 15 Millicuries) carries an average Medicare payment of $46.85 — 36% above the national benchmark of $34.35. 15 providers across the state submitted claims for this procedure in 2023, performing 37 total services. Individual payments in OR ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Oregon is $72.32, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Oregon sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Medical Supplies procedures, the estimated commercial insurance price in Oregon lands near $134.86, with self-pay cash prices typically around $63.87. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Technetium Tc-99m Mebrofenin, Diagnostic, Per Study Dose, Up To 15 Millicuries cost in Oregon?

The average Medicare payment for Technetium Tc-99m Mebrofenin, Diagnostic, Per Study Dose, Up To 15 Millicuries in Oregon is $46.85, which is 36% above the national average of $34.35. Providers in OR typically bill $72.32 for this procedure.

What does Technetium Tc-99m Mebrofenin, Diagnostic, Per Study Dose, Up To 15 Millicuries cost with insurance in Oregon?

With commercial insurance in Oregon, Technetium Tc-99m Mebrofenin, Diagnostic, Per Study Dose, Up To 15 Millicuries costs an estimated $134.86. Without insurance, the estimated cash price is $63.87. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Technetium Tc-99m Mebrofenin, Diagnostic, Per Study Dose, Up To 15 Millicuries in Oregon?

15 providers in Oregon billed Medicare for Technetium Tc-99m Mebrofenin, Diagnostic, Per Study Dose, Up To 15 Millicuries in 2023, performing 37 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Technetium Tc-99m Mebrofenin, Diagnostic, Per Study Dose, Up To 15 Millicuries cheaper in Oregon than the national average?

No — Technetium Tc-99m Mebrofenin, Diagnostic, Per Study Dose, Up To 15 Millicuries costs 36% above the national average in Oregon. The state average Medicare payment is $46.85 compared to $34.35 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial